BTCY

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 2/16/2017
Contact Info
  • 275 Shoreline Dr.
  • Suite 150
  • Redwood City, CA 94065

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001630113
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NV, USA
Year of Inc. 2012
Employees 7 a/o Nov 10, 2015
Company Officers/Contacts
Waqaas Al-Siddiq President, CEO
Tom Nelson Advisory Director
John Rother Advisory Director
Bernard Rice Advisory Director
Danny Sands Advisory Director
Nayyar Razvi Advisory Director
David Liepert Advisory Director
Company Directors
Waqaas Al-Siddiq Chairman
Norman Betts Independent Director
Dave Rosa Independent Director
Service Providers
Accounting/Auditing Firm
SRCO Professional Corporation, Charted Accountant
15 Wertheim Court, Suit 409
Richmond Hill, ONT, L4B 3H7
Canada
 
Securities Counsel
Ruskin Moscou Faltischek, PC OTCQX Sponsor
1425 RXR Plaza
East Tower, 15th Floor
Uniondale, NY, 11556
United States
 
Investor Relations Firm
Liolios Group, Inc.
20371 Irvine Ave
Suite A-100
Newport Beach, CA, 92660
United States
 
Company History
  • Formerly=MetaSolutions, Inc. until 2-2016
BTCY Security Details
Share Structure
Market Value1 $64,700,663 a/o Mar 24, 2017
Authorized Shares 125,000,000 a/o Feb 05, 2016
Outstanding Shares 26,408,434 a/o Feb 10, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 4,500,000 a/o Aug 09, 2016
Par Value 0.001
Shareholders
Shareholders of Record 1,276 a/o Aug 09, 2016
Short Selling Data
Short Interest 2,017 (6.16%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security